Circulating activated platelets in myeloproliferative disorders
Authors:
- D. TschöpeDTD. Tschöpe
- J. EsserJEJ. Esser
- C. MenzelCMC. Menzel
- H.K. NieuwenhuisHNH.K. Nieuwenhuis
- W. SchneiderWSW. Schneider
- 1 February 1991
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 61 (3) , 271-278
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Flow‐cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated plateletsCytometry, 1990
- Use of a monoclonal antibody to measure the surface expression of thrombospondin following platelet activationEuropean Journal of Biochemistry, 1988
- Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulationBlood, 1987
- Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants on human blood platelet thrombospondinEuropean Journal of Biochemistry, 1986
- A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.Journal of Cell Biology, 1985
- Bleeding and thrombosis in the myeloproliferative disordersBlood, 1984
- Abnormal Platelet Serotonin Uptake and Binding Sites in Myeloproliferative DisordersThrombosis and Haemostasis, 1984
- Biochemical and Metabolic Aspects of Platelet Dysfunction in Chronic Myeloproliferative DisordersThrombosis and Haemostasis, 1982
- Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function.Journal of Clinical Pathology, 1977
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962